Startseite The crystal structure of (E)-amino(2-(4-methylbenzylidene)hydrazineyl)methaniminium 4-methylbenzoate, C9H13N4 + C8H7O2 −
Artikel Open Access

The crystal structure of (E)-amino(2-(4-methylbenzylidene)hydrazineyl)methaniminium 4-methylbenzoate, C9H13N4 + C8H7O2

  • Zeliha Atioğlu ORCID logo EMAIL logo und Hüseyin Kekeçmuhammed
Veröffentlicht/Copyright: 22. September 2021

Abstract

Monoclinic, P21/c (no. 14), a = 14.187(15) Å, b = 10.585(11) Å, c = 11.952(13) Å, β = 113.851(16), V = 1642(3) Å3, Z = 4, R gt (F) = 0.0479, wR ref (F 2) = 0.1408, T = 296(2) K.

CCDC no.: 2108721

The asymmetric unit of the title crystal structure is shown in the figure (The N–H⃛N and N–H⃛O hydrogen bonds are shown as a dashed lines.). Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size 0.19 × 0.15 × 0.13 mm
Wavelength: MoKα radiation (0.71073 Å)
μ: 0.09 mm−1
Diffractometer, scan mode: Bruker Apex-II QUAZAR, φ and ω
θ max, completeness: 27.5°, >99%
N(hkl)measured, N(hkl)unique, R int: 13954, 3738, 0.031
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 2617
N(param)refined: 230
Programs: Bruker [1], SHELX [2, 3], WinGX/ORTEP [4], PLATON [5]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.86938 (16) 1.0358 (2) 0.4897 (2) 0.0752 (6)
H1A 0.875799 0.989545 0.424033 0.113*
H1B 0.932107 1.028461 0.561874 0.113*
H1C 0.856407 1.123201 0.467148 0.113*
C2 0.78122 (14) 0.98292 (18) 0.51473 (17) 0.0531 (5)
C3 0.76640 (15) 1.0187 (2) 0.6183 (2) 0.0621 (5)
H3 0.811777 1.075861 0.672612 0.075*
C4 0.68618 (15) 0.97140 (19) 0.64232 (18) 0.0577 (5)
H4 0.677829 0.996996 0.712200 0.069*
C5 0.61778 (13) 0.88581 (16) 0.56281 (15) 0.0455 (4)
C6 0.63275 (15) 0.8489 (2) 0.45992 (17) 0.0568 (5)
H6 0.587864 0.791132 0.405823 0.068*
C7 0.71355 (15) 0.8970 (2) 0.43687 (17) 0.0587 (5)
H7 0.722404 0.870887 0.367459 0.070*
C8 0.53151 (13) 0.83450 (17) 0.58509 (16) 0.0482 (4)
H8 0.488801 0.775051 0.530932 0.058*
C9 0.39977 (12) 0.85048 (16) 0.77275 (14) 0.0413 (4)
N1 0.51275 (10) 0.86838 (14) 0.67621 (13) 0.0455 (3)
N2 0.42814 (11) 0.81223 (14) 0.68457 (14) 0.0458 (4)
HN2 0.3917 (15) 0.752 (2) 0.6307 (18) 0.056 (5)*
N3 0.45274 (13) 0.93904 (16) 0.85239 (15) 0.0524 (4)
HN3 0.4290 (16) 0.962 (2) 0.909 (2) 0.069 (6)*
HN4 0.5082 (17) 0.970 (2) 0.8464 (19) 0.070 (7)*
N4 0.31861 (12) 0.79866 (17) 0.78045 (16) 0.0526 (4)
HN5 0.2835 (16) 0.740 (2) 0.726 (2) 0.061 (6)*
HN6 0.3040 (15) 0.8222 (19) 0.846 (2) 0.062 (6)*
C10 −0.01887 (17) 0.1763 (2) 0.2373 (2) 0.0689 (6)
H10A −0.077803 0.173381 0.257468 0.103*
H10B 0.014108 0.095144 0.252125 0.103*
H10C −0.040553 0.197979 0.152488 0.103*
C11 0.05592 (13) 0.27439 (16) 0.31529 (16) 0.0482 (4)
C12 0.04366 (14) 0.33101 (17) 0.41305 (17) 0.0514 (4)
H12 −0.011166 0.306817 0.432040 0.062*
C13 0.11115 (13) 0.42268 (16) 0.48294 (16) 0.0463 (4)
H13 0.100970 0.459354 0.547888 0.056*
C14 0.19370 (11) 0.46053 (14) 0.45742 (13) 0.0363 (3)
C15 0.20734 (13) 0.40213 (16) 0.36109 (16) 0.0458 (4)
H17 0.263046 0.424782 0.343162 0.055*
C16 0.13943 (14) 0.31094 (17) 0.29151 (16) 0.0507 (4)
H16 0.150125 0.273318 0.227291 0.061*
C17 0.26092 (13) 0.56737 (16) 0.52905 (14) 0.0422 (4)
O1 0.22962 (11) 0.63005 (13) 0.59552 (12) 0.0644 (4)
O2 0.34371 (10) 0.59063 (13) 0.51714 (12) 0.0581 (4)

Source of material

Two gram (0.0181 mol) aminoguanidine hydrochloride salt in a 100 mL round-bottom flask is dissolved in a mixture of purified water (15 mL) and methanol (15 mL), and 2.346 mL (0.0199 mol) of 4-methylbenzaldehyde is added. After mixing in a magnetic stirrer at room conditions for 24 h, it is neutralized with equivalent 0.72 g (1 eq) NaOH. In order for the precipitation to occur well, it is kept in the refrigerator for 30–45 min, the precipitated material is filtered with a crucible, washed with distilled water (3 × 5 mL) and dried under vacuum. After waiting for one day, crystallization is done in ethanol and water (EtOH/H2O). To purify the substance, it is kept in the refrigerator for 24 h. The crystalline material formed is filtered, washed in cold ethanol, then dried in a vacuum oven (yield: 94%).

Experimental details

The H atoms of the NH and NH2 groups were located from a difference- Fourier map and refined freely [N2—HN2 = 0.90(2), N3—HN3 = 0.91(2), N3—HN4 = 0.88(2), N4—HN5 = 0.89(2) and N4—HN6 = 0.92(2) Å]. All C-bound H atoms were positioned geometrically and refined using a riding model, with C—H = 0.93 and 0.96 Å, for aryl and methyl H-atoms, respectively. The U iso(H) were allowed at 1.5U eq(Cmethyl) or 1.2U eq(Cnon-methyl).

Comment

During the 1960s, Wyeth laboratories, Inc., Philadelphia, produced a series of benzylidene aminoguanidines during the search for new and improved antihyperten-sive medicines. In 1969, one of the chemicals in this class, E-2,6-dichlorobenzylidene aminoguanidine acetate, was found as a new, strong hypotensive agent [6].

The title salt is composed of one cation and one anion in the asymmetric unit. The cations and the anions of the title salt are nearly co-planar: the maximum deviations from the mean plane of the non–H atoms are −0.592(1) Å for O2, 0.328(2) Å for N3 and 0.250(2) Å for N4, respectively.

The cation group is stabilized by the N—H ⃛ N hydrogen bond [N3—HN4/N1: HN4/N1 = 2.33(2) Å, N3 ⃛ N1 = 2.677(4) Å with angle at HN4 = 103.9(16)], forming a S(5) ring [7].

In the cation, the C—N bond distances are N3—C9 = 1.331(2) Å and N4—C9 = 1.312(2) Å. The C=N bond distance is N1—C8 = 1.273(2) and N2—C9 = 1.334(2) Å. The N—N bond distance of 1.3852(19) Å is shorter than a single bond and indicating significant delocalization along the NNC(NH2)N moiety. All bond length and bond angles in the title salt can be compared with those of the related compounds which are 2-((2,6-dichlorophenyl)methylene)hydrazinecarboxamide acetate (CSD refcode HIVYOB: orthorhombic space group: Pbca (61), a = 13.389(5), b = 11.007(6), c = 17.342(5) Å, Z = 4) [8] and N’’-[(2,6-dichlorophenyl)methylidene] carbonohydrazonic diamide (Form I (CSD refcode SOMZOM): monoclinic space group: P21/c (14), a = 16.3082(4) Å, b = 8.2933(3) Å, c = 7.4489(3) Å, β = 98.201(3), Z = 4; Form II (SOMRUK): triclinic space group: P 1 (2), a = 7.9018(3) Å, b = 10.8460(7) Å, c = 12.9559(8) Å, α = 78.313(5), β = 72.515(4), γ = 83.119(4), Z = 4) [9].

In the crystal, the cations and anions of the title salt which are co-planar are linked by N—H ⃛ O hydrogen bonds N2—HN2/O1: HN2/O1 = 2.52(2) Å, N2/O1 = 3.219(4) Å with angle at HN2 = 134.4(18) Å, N2—HN2/O2: HN2/O2 = 2.12(2) Å, N2/O2 = 3.001(4) Å with angle at HN2 = 166(2) and N4—HN5/O1: HN5/O1 = 1.85(2) Å, N4/O1 = 2.722(4) Å with angle at HN5 = 167(2)], forming the R 1 2 (6) and R 1 2 (4) ring motifs. Furthermore the cations and anions are connected by the N—H ⃛ O [N3—HN3/O2: HN3/O2 = 2.17(2) Å, N3/O2 = 2.972(4) Å with angle at HN3 = 147.6(19), N3—HN4/O2: HN4/O2 = 2.44(2) Å, N3/O2 = 3.115(4) Å with angle at HN4 = 134.2(18) and N4—HN6/O2: HN6/O2 = 2.10(2) Å, N4/O2 = 2.948(4) Å with angle at HN6 = 152(2)], C—H ⃛ O [C4—H4/O1: H4/O1 = 2.56 Å, C4/O1 = 3.322(4) Å with angle at H4 = 140] and very weak π-π stacking interactions [Cg1(C2—C7)⃛Cg2(C11—C16) i  = 3.916(4) Å, angle = 7.45(9) and slippage = 1.320 Å; Cg2(C11—C16) ⃛ Cg1(C2—C7) i  = 3.916(4) Å, angle = 7.45(9) and slippage = 1.78 Å for symmetry operation (i): 1 − x, 1 − y, 1 − z], generating the molecular layers paralel to the (100) plane.


Corresponding author: Zeliha Atioğlu, Avionics Department, School of Applied Sciences, Cappadocia University, 50420, Mustafapaşa, Ürgüp, Nevşehir, Turkey, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEX2 and SAINT. Bruker; AXS Inc.: Madison, WI, USA, 2012.Suche in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar PubMed

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/S2053229614024218.Suche in Google Scholar PubMed PubMed Central

4. Farrugia, L. J. WinGX and ORTEP for windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854; https://doi.org/10.1107/s0021889812029111.Suche in Google Scholar

5. Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. 2009, D65, 148–155; https://doi.org/10.1107/s090744490804362x.Suche in Google Scholar PubMed PubMed Central

6. Baum, T., Eckfeld, D. K., Metz, N., Dinish, J. L., Rowles, G., Van Pelt, R., Shropshire, A. T., Fernandez, S. P., Gluckman, M. I., Bruce, W. F. 2, 6–dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent. Experientia 1969, 25, 1066–1067; https://doi.org/10.1007/bf01901433.Suche in Google Scholar

7. Bernstein, J., Davis, R. E., Shimoni, L., Chang, N.-L. Patterns in hydrogen bonding: functionality and graph set analysis in crystals. Angew Chem. Int. Ed. Engl. 1995, 34, 1555–1573; https://doi.org/10.1002/anie.199515551.Suche in Google Scholar

8. Tanaka, R., Hirayama, N. Crystal structure of guanabenz acetate. Anal. Sci. 2008, 24, x5–x6; https://doi.org/10.2116/analscix.24.x5.Suche in Google Scholar

9. Kathuria, D., Chourasiya, S. S., Wani, A. A., Singh, M., Sahoo, S. C., Bharatam, P. V. Geometrical isomerism in guanabenz free base: synthesis, characterization, crystal structure, and theoretical studies. Cryst. Growth Des. 2019, 19, 3183–3191; https://doi.org/10.1021/acs.cgd.9b00026.Suche in Google Scholar

Received: 2021-08-15
Accepted: 2021-09-09
Published Online: 2021-09-22
Published in Print: 2021-12-20

© 2021 Zeliha Atioğlu and Hüseyin Kekeçmuhammed, published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Redetermination of the crystal structure of 3-bromonitrobenzene at 200 K, C6H4BrNO2 – temperature effects on cell constants
  4. Crystal structure of (E)-ethyl 2-((4-oxo-4H-chromen-3-yl)methyleneaminooxy)acetate, C14H13NO5
  5. Crystal structure of (8R,10R,14R, Z)-2-((3–Fluoropyridin-4-yl) methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6, 6-trimethyltetrahydro-2H-pyran-2-yl) hexadecahydro-3H-cyclopenta[a] phenanthren-3-one, C36H52FNO3
  6. Crystal structure of [6,6′-((1E,1′E)-(propane-1,3- diylbis(azaneylylidene))bis(methaneylylidene)) bis(3-chlorophenol)-κ4N,N′,O,O′] copper(II), C17H14Cl2CuN2O2
  7. The crystal structure of 6-amino-2-carboxypyridin-1-ium bromide, C6H7BrN2O2
  8. Redetermination of the crystal structure of bis[N,N′-ethylenebis(acetylacetoniminato)nickel(II)] sodium perchlorate, C24H36ClN4NaNi2O8
  9. The crystal structure of 3-methyl-2,6-dinitrophenol, C7H6N2O5
  10. The crystal structure of 5-chloro-2-(quinolin-8-yl)isoindoline-1,3-dione, C17H9ClN2O2
  11. Crystal structure of trans-tetraaqua-bis{2-carboxy-4-((5-carboxypyridin-3-yl)oxy)benzoato-κ1 N}cobalt(II) dihydrate C28H28O20N2Co
  12. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-(p-tolyl)furan, C23H23BrO2
  13. The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(benzo[d][1,3]dioxol-5-ol ato-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV)-dichloromethane(1/1), C27H25N3O10Ti
  14. Crystal structure of (((1E,1′E)-1,2-phenylenebis(methaneylylidene))bis(hydrazin-1-yl-2-ylidene))bis(aminomethaniminium) dinitrate C10H16N10O6
  15. Crystal structure of catena-poly[triaqua-(μ 2-1,3-di(1H-imidazol-1-yl)propane-κ 2 N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ 1 O)nickel(II)]N,N′-dimethylformamide (1/1), C28H35N8O8Ni
  16. The crystal structure of 3,3′-[1,4-phenylenebis(methylene)]bis(1-ethenyl-1H-imidazol-3-ium) dichloride – dichloromethane – water (1/1/1), C19H24Cl4N4O1
  17. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-propyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C13H22F12N4P2
  18. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)tin(IV), C12H8Cl4Sn
  19. Synthesis and crystal structure of 4-acetylpyrene, C18H12O
  20. Crystal structure of 2,2′-(butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(4-methoxyphenol), C20H24N2O4
  21. The crystal structure of (E)-2-(((5-((triphenylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol, C27H21N3OS2Sn
  22. Crystal structure of diaqua-bis(μ2-6-phenylpyridine-2-carboxylate-κ3N,O:O)-bis(6-phenylpyridine-2-carboxylato-κ2N,O)lead(II) – N,N-dimethylformamide – water (1/2/4), C54H58N6O16Pb2
  23. Crystal structure of methyl 4-acetoxy-3-methoxybenzoate, C11H12O5
  24. Crystal structure of 2,2′-(propane-1,3-dilylbis(azaneylylidene))bis(methanylylidene)bis(4-methylphenol), C19H22N2O2
  25. Crystal structure of dichlorido-bis(4-methylphenyl-κC1)tin(IV), C14H14Cl2Sn
  26. Crystal structure of methyl (E)-3-(4-acetoxyphenyl)acrylate, C12H12O4
  27. The crystal structure of bis(benzoato-κ2 O,O′)-(2,9-dimethyl-1,10-phenanthroline-κ2 N,N′)-copper(II), C28H22CuN2O4
  28. Crystal structure of (8R,10R,14R,Z)-12-hydroxy-2-((6-methoxypyridin-2-yl)methylene)-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one–water (2/1), C37H56NO4.5
  29. Crystal structure of dimethyl-bis(4-bromophenyl-κC1)tin(IV), C14H14Br2Sn
  30. The crystal structure of the cocrystal di-μ2-chlorido-octamethyl-di-μ3-oxido-bis(2,3,4,5-tetrafluorobenzoato-κ2 O,O′)tetratin(IV) ─ octamethyl-di-μ3-oxido-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O′)-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O;O′)tetratin(IV) C58H54Cl2F24O16Sn8
  31. Crystal structure of 3-iodo-N 2-(2-methyl-1-(methylsulfonyl)propan-2-yl)-N 1-(2-methyl-4-(perfluoropropan-2-yl)phenyl)phthalamide, C23H22F7I1N2O4S1
  32. Crystal structure of 1-(2-(4-bromophenyl)-2,3-dihydro-1H-benzo[e]indol-1-yl)-naphthalen-2-ol – dichloromethane – dimethyl sulfoxide (1/1/1), C28H18BrNO·CH2Cl2·C2H6SO
  33. Crystal structure of [meso-5,7,7,12,14,14,-hexamethyl-1,4,8,11-tetraazacyclotetradecane]nickel(II) diperchlorate – dimethylsulphoxide (1/2), C20H48Cl2N4NiO10S2
  34. Crystal structure of 1,1′-(1,3-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S:S) palladium(II), C26H18N6PdS4
  35. The crystal structure of bis(6-phenylpyridine-2-carboxylato-κ2 N,O)copper(II), C24H16N2O4Cu
  36. Crystal structure of dichlorido-bis(4-chlorophenyl-κC)-bis(triphenylarsine oxide-κO)tin(IV), C48H38As2Cl4O2Sn
  37. Crystal structure of (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane-κ 8 N 2, O 6) potassium cyclopentadienide, [K([2.2.2]crypt)]Cp, C23H41KN2O6
  38. The crystal structure of bis(2-oxidopyridin-1-ium-3-carboxylato-κ2O,O′)-(phenantroline-κ2N,N′)manganese(II) - methanol (1/3), C27H28N4O9Mn
  39. Crystal structure of 4-(dimethylamino)pyridinium dibromido-tris(4-chlorophenyl-κC)stannate(IV), C25H23Br2Cl3N2Sn
  40. Crystal structure of (3E,5E)-1-(4-cyanobenzenesulfonyl)-3,5-bis(3-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C27H20Cl2F2N2O3S
  41. Crystal structure of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-trifluoromethyl)benzenesulfonyl)piperidin-4-one, C26H18F5NO3S
  42. Crystal structure of chlorido-(4-methyl-2-((phenylimino)methyl)phenolato-κ2 N,O)-(pyridine-κ1 N)platinum(II), C19H17ClN2OPt
  43. Crystal structure of (4-methylbenzyl)(triphenyl)phosphonium chloride dihydrate, C26H28ClO2P
  44. The crystal structure of poly[μ2-chlorido-(μ2-1,2-bis(4-pyridyl)ethane-κ2N:N′silver(I)], C12H12AgClN2
  45. Crystal structure of poly[(μ4-benzene-1,2,4,5-tetracarboxylato)-bis(μ2-adipohydrazide)dicadmium], C11H15N4O6Cd
  46. The crystal structure of (E)-N′-(butan-2-ylidene)isonicotinohydrazide 0.5 hydrate C10H13N3O·0.5H2O
  47. The crystal structure of bis(6-phenylpyridine-2-carboxylate-κ2 N,O)-(2,2′-bipyridine-κ2 N,N′)zinc(II) monohydrate, C34H26N4O5Zn
  48. The crystal structure of (1R *,2S *)-1,2-bis(2-fluorophenyl)-3,8-dimethoxyacenaphthene-1,2-diol, C26H20F2O4
  49. Crystal structure of catena-poly[(μ2-1-((2-ethyl-4-methyl-1H-imidazol-1-yl)methyl)-1H-benzotriazole-κ2N:N′)-(nitrato-κ2O,O′)silver (I)], C13H15Ag1N6O3
  50. The crystal structure of [(phenantroline-κ2 N,N′)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)cobalt(II)]monohydrate, C36H26N4O5Co
  51. Crystal structure of (1E)-N-[(1E)-1-(4-chlorophenyl)ethylidene]-2-[1-(4-chlorophenyl)ethylidene]hydrazine-1-carbohydrazonamide, C 17 H 17 Cl 2 N 5
  52. The crystal structure of (E)-2-((tert-butylimino)methyl)-4-chlorophenol, C11H14ClNO
  53. Crystal structure of all-cis-2,4,6-trihydroxycyclohexane- 1,3,5-triaminium chloride sulfate, C6H18ClN3O7S
  54. Crystal structure of dichlorido-bis(dimethyl sulfoxide-κO)bis(4-methylphenyl-κC 1)tin(IV), C18H26Cl2O2S2Sn
  55. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)(2,2′-bipyridyl-κ 2 N,N′)tin(IV), C22H16Cl4N2Sn
  56. Redetermination of the crystal structure of (E)-5-bromo-2-hydroxybenzaldehyde oxime, C 7 H 6 BrNO 2
  57. The crystal structure of (E)-amino(2-(4-methylbenzylidene)hydrazineyl)methaniminium 4-methylbenzoate, C9H13N4 + C8H7O2
  58. Crystal structure of 2-chloro-3-(isopentylamino)naphthalene-1,4-dione, C 15 H 16 ClNO 2
  59. The crystal structure of bis(2-acetyl-5-methoxyphenyl)carbonate 1.5 hydrate, C19H18O7
  60. The crystal structure of poly[(μ 4-4,4′-(azanediylbis(methylene))dibenzoato-κ 4 O:N:O′:Oʺ)zinc(II)], C16H13NO4Zn
  61. The crystal structure of catena-poly[(1,10-phenanthroline-k2N,N′)-(μ3-tetraoxidomoybdato(VI)-k3O:O′:O″)manganese(II)] C12H8N2O4MoMn
  62. Crystal structure of catena-poly[(4-hydroxyl-5-(methoylcarbonyl)thiophene-2-carboxylato-κ1 O)-(μ2-piperazine-1,4-diylbis(pyridin-4-ylmethanone)-κ2 N:N′)silver(I)] monohydrate, C23H23AgN4O8S
  63. Crystal structure of bis(4-bromo-2-(((3-bromopropyl)imino)methyl)phenolato-κ2N,O)-oxido-vanadium(IV), C20H20Br4N2O3V
  64. The crystal structure of (2a′S,2a1′S,3R,5a′S,7′R)-5-(furan-3-yl)-2a′,2a1′-dihydroxy-7′-methyldecahydro-2H-spiro[furan-3,6′-naphtho[1,8-bc]furan]-2,2′(2a′H)-dione, C19H22O7
  65. The crystal structure of 3-bromopicolinic acid, C6H4BrNO2
  66. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S,S) platinum(II), C26H18N6PtS4
  67. Synthesis and crystal structure of 5-(8-((3-carboxyazetidin-1-ium-1-yl)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxybenzenesulfonate monohydrate, C20H19NO10S
  68. The crystal structure of 3-amino-5-carboxypyridin-1-ium bromide, C6H7BrN2O2
  69. The crystal structure of (2-hydroxy-5-methyl-phenyl)-(1H-pyrazol-4-yl)-methanone hemihydrate, C11H10.5N2O2.5
  70. Crystal structure of tetraaqua-(2-(4-formylphenoxy)acetato-k1O)cadmium(II), C18H22O12Cd
  71. Crystal structure of diethyl 6,12-dimethyl-3,9-di-p-tolyl-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5-dicarboxylate, C32H38N2O4
  72. Crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl)ethylidene)-4-hydroxy – tetrahydrofuran (2/1), C17H16ClFN2O2.5
Heruntergeladen am 30.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0330/html
Button zum nach oben scrollen